RUNX3, RASSF1A and Reprimo promoter methylation may be potential useful noninvasive biomarkers for the detection of GC, but other p16, CDH1, MLH1, p15, APC, GSTP1, and MGMT genes show a low diagnostic effect for GC in blood samples. Here, RUNX3 is linked to gastric cancer.